<<

to enable recombination-based immune e-mails: [email protected]; expressed in units of , in which the diversification might drive a type of [email protected] is 511 kiloelectronvolts and chromosomal abnormality known as a chro- the mass is 938 megaelectronvolts (see mosomal trans­location, which could lead to go..com/2bwkrqz). And a lower limit7 of –22 cancer. Much like the DNA loops themselves, 1. Zhang, Y. et al. Nature 573, 600–604 (2019). about 10 eV comes from the fact that, when these insights into the role of chromosomal 2. Zhang, X. et al. Nature 575, 385–389 (2019). these are described as in quan- 3. Rao, S. S. et al. Cell 159, 1665–1680 (2014). architecture might help to reveal connec- 4. Ji, Y. et al. Cell 141, 419–431 (2010). tum mechanics, their cannot be tions between areas that were previously 5. Hu, J. et al. Cell 163, 947–959 (2015). larger than the size of a dwarf — other­ considered to be separate. 6. Jain, S., Ba, Z., Zhang, Y., Dai, H. Q. & Alt, F. W. Cell 174, wise, such would show deviations 102–116 (2018). 7. Dong, J. et al. Nature 525, 134–139 (2015). from their observed structure. Ferenc Livak and André Nussenzweig are in 8. Seitan, V. C. et al. Nature 476, 467–471 (2011). The particles associated with dark the Laboratory of Genome Integrity, National 9. Rao, S. S. P. et al. Cell 171, 305–320 (2017). can be thought of as classical waves 10. Canela, A. et al. Cell 170, 507–521 (2017). Cancer Institute, National Institutes of Health, that have an oscillation directly Bethesda, Maryland 20892, USA. This article was published online on 30 October 2019. proportional to the axion mass. There are several techniques that can be used to look High-energy for such waves, and the most appropriate one depends mainly on the frequency range that is being considered. For that have below 10–17 eV (corresponding to a frequency Link between of tens of millihertz), the waves oscillate extremely slowly. If are held in and probed the strong of a device known as a , these waves will produce Gianpaolo Carosi changes in the frequency at which the spins of the antiprotons precess. Ultrasensitive experiments on trapped antiprotons provide The Antibaryon Symmetry Experi- 8 a window onto possible differences between matter and ment (BASE) at the European -physics antimatter. Now they could also shed on the identity of laboratory CERN near Geneva, Switzerland, uses this technique. The BASE collaboration dark matter — the ‘missing’ mass in the . See p.310 relies on ultrasensitive Penning traps, which use specialized configurations of magnetic and electric fields to trap antiprotons in a Two of the most intriguing mysteries in limit to the number of axions that can exist in high- environment. This set-up allows modern are the apparent prepon- a certain volume of . As a result, axion the antiprotons to be measured continuously derance of ordinary matter over antimatter dark matter has an extremely wide range of for long periods of , and to be shuttled and the nature of dark matter, which accounts potential masses. Astrophysical measure- back and forth between different measure- for about 85% of the mass in the Universe1. ments place an upper limit6 on the mass of ment chambers without running into ordinary Dark matter has made its presence known about 10–2 (eV). This value is matter and being annihilated. One of the main only through its gravitational effects on astrophysical objects. Therefore, whatever type of particle it is made of must have feeble Frequency (Hz) interactions with other matter. One leading 10–8 10–7 10–6 10–5 10–4 10–3 10–2 1 candidate is the axion — a light neutral particle 10 Combined limit that was originally postulated to explain why 100 the lacks a measurable electric moment2. Until now, researchers have looked 10–1 for evidence of couplings between axion dark Experimental limit 10–2 matter and only ordinary particles such as , and nuclei3,4. On page 310, 10–3 5 Smorra et al. report a search for a coupling (GeV) 10–4 between axion dark matter and antimatter Astrophysical limit –5

(specifically, antiprotons). parameter Interaction 10 Every known particle can be classified as –6 either a boson or a . Bosons have inte- 10 ger (intrinsic angular ), and 10–7 include the (spin-1) and the (spin-0) 10–22 10–21 10–20 10–19 10–18 10–17 . By contrast, have Axion mass (eV) half-integer spin, and include the (spin-1/2) electron. The axion is expected to be a spin-0 Figure 1 | Constraining axion– interactions. Particles called axions could account for the elusive boson that has odd parity, which means dark matter that pervades the Universe. Smorra et al.5 present experimental limits on the coupling between that its wavefunction changes sign if spatial axion dark matter and antiprotons. These bounds are expressed in terms of an axion–antiproton interaction co­ordinates are flipped. parameter and vary with the axion mass or the frequency of the axion if the particle is represented as a Unlike fermionic dark matter (such as (eV, electronvolts; GeV, gigaelectronvolts; Hz, hertz). The combined limit represents the strongest constraint dark-matter candidates called weakly inter- that could be set by the experimental data. An astrophysical limit, as estimated by the authors, is included for acting massive particles, WIMPs), there is no comparison. The coloured and hatched areas show the parameter space that is excluded.

Nature | Vol 575 | 14 November 2019 | 293 ©2019 Spri nger Nature Li mited. All ri ghts reserved. ©2019 Spri nger Nature Li mited. All ri ghts reserved.

News & views goals of the collaboration is to determine the matter) is an exciting prospect, and could prove 2. Kim, J. E. & Carosi, G. Rev. Mod. Phys. 82, 557–601 intrinsic of the antiproton. to be the key to unlocking several mysteries in (2010). 3. Graham, P. W., Irastorza, I. G., Lamoreaux, S. K., Lindner, A. This quantity can be calculated to extremely cosmology as technology improves. & van Bibber, K. A. Annu. Rev. Nucl. Part. Sci. 65, 485–514 high precision using the of (2015). — the current explanation Gianpaolo Carosi is in the Rare Event Detection 4. Stadnik, Y. V. & Flambaum, V. V. Preprint at https://arxiv. org/abs/1806.03115 (2018). of the Universe’s particles and forces. Group, Physical and Life Directorate, 5. Smorra, C. et al. Nature 575, 310–314 (2019). In 2017, Smorra et al. made an ultraprecise Lawrence Livermore National Laboratory, 6. Raffelt, G. G. in Axions: Lecture Notes in Physics Vol. 741 (eds Kuster, M., Raffelt, G. & Beltrán, B.) 51–71 (Springer, Livermore, California 94550, USA. measurement of the antiproton’s magnetic 2008). 9 moment (to one part in a billion) , constrain- e-mail: [email protected] 7. Hui, L., Ostriker, J. P., Tremaine, S. & Witten, E. Phys. Rev. D ing many theories of physics beyond the 95, 043541 (2017). 8. Smorra, C. et al. Eur. Phys. J. Spec. Top. 224, 3055–3108 standard model. The key to their method was 1. Collaboration. Preprint at https://arxiv.org/ (2015). the simultaneous measurement of the spin abs/1807.06209 (2018). 9. Smorra, C. et al. Nature 550, 371–374 (2017). precession and a quantity called the cyclo- tron frequency, which describes the cyclical Medical research motion of an antiproton in a trap. This task was challenging, because it required meticulous control of a device known as a magnetic bottle to non-destructively determine the spin state ‘Undruggable’ cancer of the antiproton. The group’s measurement required hundreds of experiments, each of protein targeted which lasted for almost an hour, taking place over several months. Roy S. Herbst & Joseph Schlessinger In the current paper, Smorra and colleagues, who include members of the BASE col- A molecule has now been characterized that acts to inhibit laboration, analysed the data from these a cancer-causing form of KRAS protein and stimulate the experiments. They proposed that waves immune system. The inhibitor is one of the first of its kind to corresponding to axion dark matter that oscillated at between 10–8 and show anticancer activity in the clinic. 10–2 hertz would shift the spin-precession frequency in a small but measurable way if the axion coupling to antiprotons was suf- Mutations in the gene KRAS are the most These inhibitors successfully prevent activation ficiently strong. Although no axion signal frequent drivers of tumour development of the protein in animal models, but none has was detected, Smorra et al. constrained across the spectrum of human cancers1. had any effect on tumours in patients. Canon the parameter that quantifies axion– Despite this prevalence, mutant KRAS et al. characterized another small-molecule antiproton interactions to values greater than protein has remained an intractable thera- inhibitor, AMG 510, that forms a covalent bond 0.1–0.6 gigaelectronvolts in the axion mass peutic target. Writing in Nature, Canon et al.2 with GDP‑bound KRASG12C (Fig. 1c). AMG 510 range from 2 × 10−23 eV to 4 × 10−17 eV (Fig. 1). describe a small molecule that binds one form has similar structural properties to one of the These limits are as much as 105 stronger of mutant KRAS with high specificity and sensi­ previous inhibitors, ARS-1620, but has one than astrophysical constraints (as estimated tivity, inhibiting the protein. The authors use key difference — it binds a structure called a by the authors), which consider how axions animal models to analyse how the inhibitor cryptic surface groove that forms in KRASG12C, might have been produced by antiprotons in works, and show that it can shrink tumours in and so recognizes the mutant protein with high the 1987A. patients. This is among the first evidence of a specificity. Future should aim to further constrain clinical response to a specific KRAS inhibitor. The authors showed that AMG 510 inhibits the axion–antiproton coupling and to look for KRAS is an enzyme that controls a signalling the exchange of GDP for GTP more potently evidence of interactions between axion dark pathway crucial for cell growth, differentia- than does ARS-1620. Moreover, AMG 510 matter and other forms of antimatter, such tion and survival. The inactive protein is strongly inhibits phosphorylation of the as (the of electrons). bound by a guanosine diphosphate (GDP) protein ERK (a known effector of KRAS activ- One key finding from these studies could be molecule — replacement of GDP by guanosine ity) in cells harbouring KRASG12C, and impairs the observation that dark matter couples to triphosphate (GTP) facilitates conformational cell proliferation. antimatter in different ways from its couplings changes in KRAS that allow the enzyme to Next, Canon and colleagues turned to mice to ordinary matter — a result that might help to bind and activate downstream effector mol- carrying KRASG12C tumour cells taken from explain why there is a predominance of matter ecules (Fig. 1a). Nearly all cancer-promoting patients. Treatment with AMG 510 at a con- over antimatter in the Universe. KRAS mutations prevent GTP breakdown, centration of 100 milligrams per of Smorra and colleagues have highlighted leaving KRAS in a permanently active state3 body weight resulted in tumour regression, a growing trend in high-energy physics, (Fig. 1b). One such mutation involves substi- but the cancer subsequently returned. At whereby exquisitely precise measurements tution of a glycine amino-acid residue for a 200 mg kg−1, however, AMG 510 triggered are used to nail down fundamental particle cysteine residue. The resulting mutant pro- permanent tumour regression in eight out parameters and to look for evidence of phys- tein, KRASG12C, is found infrequently in various of ten mice. Of note, the robust potency with ics beyond that of the standard model. Axion cancers. It is most prevalent in lung cancer, which AMG 510 triggers cell death raises the dark matter, which has a vast potential mass and is responsible for approximately 12% of possibility that it becomes covalently attached range and extraordinarily weak predicted non-small cell lung cancers4,5. to other cysteine-containing proteins, in addi- couplings, has gone through a renaissance in In the past few years, several irreversible tion to KRASG12C — something that should be terms of innovative detection techniques. The small-molecule inhibitors have been devel- investigated in future, if the molecule is to search for a preferred coupling of axion dark oped6–8 that bind covalently to a pocket in be regularly used in patients. matter to antimatter (as opposed to ordinary GDP‑bound KRASG12C to inhibit GTP binding. Interestingly, mice showed a durable

294 | Nature | Vol 575 | 14 November 2019 ©2019 Spri nger Nature Li mited. All ri ghts reserved. ©2019 Spri nger Nature Li mited. All ri ghts reserved.